Disclosure Panels Details Page
Testicular Cancer Panel - Disclosures as of 08/17/2016
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Clair Beard MD | None | None | None | None | - |
| Benedito Carneiro MD, MS | None | Bayer HealthCare Bristol Myers Squibb |
None | None | ✔ |
| Nicholas Cost MD | None | None | None | None | ✔ |
| Ithaar Derweesh MD | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | NA | NA | NA | NA | ✔ |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Darren Feldman MD | Novartis Pharmaceuticals Corporation | None | None | None | ✔ |
| Daniel Geynisman MD | None | Pfizer Inc. | None | None | ✔ |
| Timothy Gilligan MD, MS | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Steven Hancock MD | Elekta Ltd. Phillips Health Care |
None | None | None | - |
| Peter Johnstone MD, MA | None | None | None | None | - |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Chad LaGrange MD, FACS | None | legal expert witness | Argos Therapeutics | None | ✔ |
| Ellis Levine MD | None | None | None | UpToDate | ✔ |
| Daniel Lin MD | GenomeDx Genomic Health, Inc. Myriad Genetic Laboratories, Inc. |
Bayer HealthCare Dendreon Corporation |
None | None | - |
| William Lowrance MD, MPH | Argos Therapeutics GenomeDx Myriad Genetic Laboratories, Inc. National Cancer Institute |
MDxHealth | None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Paul Monk MD | Arqule | None | None | None | - |
| Ndiya Ogba PhD | None | None | None | None | ✔ |
| Joel Picus MD | None | None | None | None | ✔ |
| Phillip Pierorazio MD | None | Myriad Genetic Laboratories, Inc. | None | None | ✔ |
| Edward Rampersaud MD | None | None | None | None | ✔ |
| Charles Ryan MD | Karyopharm | None | None | None | ✔ |
| Philip Saylor MD | None | None | None | None | ✔ |
| Kanishka Sircar MD | None | None | None | None | ✔ |
| Guru Sonpavde MD | Bayer HealthCare Boehringer Ingelheim GmbH Celgene Corporation Merck & Co., Inc. Onyx Pharmaceuticals, Inc. |
None | Agensys, Inc. Argos Therapeutics Bayer HealthCare Clinical Care Options/NCCN Eisai Inc. Genentech, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. sanofi-aventis U.S. Uptodate |
None | ✔ |
| Katherine Tzou MD | None | None | None | None | ✔ |
| Daniel Vaena MD | Aragon Argos Therapeutics AstraZeneca Pharmaceuticals LP Boston Biomedical Bristol Myers Squibb Celgene Corporation Eli Lilly and Company EMD Serono Exelixis Inc. Genentech, Inc. GSK Incyte Janssen Pharmaceutica Products, LP National Cancer Institute Onyx Pharmaceuticals, Inc. Pharmacyclics Tesaro TG Therapeutics TRACON |
None | None | None | ✔ |
| Alon Weizer MD, MS | None | None | None | None | - |
| James Yu MD, MHS | None | None | None | None | ✔ |